Astellas Pharma (Netherlands)

436 papers and 10.9k indexed citations i.

About

In recent decades, authors affiliated with Astellas Pharma (Netherlands) have published 436 papers, which have received a total of 10.9k indexed citations. Scholars at this organization have produced 122 papers in Urology, 101 papers in Epidemiology and 94 papers in Pulmonary and Respiratory Medicine on the topics of Urinary Bladder and Prostate Research (121 papers), Pelvic Floor Disorders (85 papers) and Prostate Cancer Treatment and Research (75 papers). Their work is cited by papers focused on Urology (3.2k citations), Rheumatology (2.5k citations) and Epidemiology (2.4k citations). Authors at Astellas Pharma (Netherlands) collaborate with scholars in The Netherlands, United States and United Kingdom and have published in prestigious journals including Journal of Clinical Oncology, Blood and PLoS ONE. Some of Astellas Pharma (Netherlands)'s most productive authors include Bertrand Tombal, Christopher R. Chapple, Zalmaï Hakimi, Emad Siddiqui and Walter Krauwinkel.

In The Last Decade

Fields of papers published by authors at Astellas Pharma (Netherlands)

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers affiliated with Astellas Pharma (Netherlands) at the time of their publication. Nodes represent fields, and links connect fields that are likely to share authors.

Countries citing scholars working at Astellas Pharma (Netherlands)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Astellas Pharma (Netherlands). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Astellas Pharma (Netherlands) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Astellas Pharma (Netherlands) more than expected).

Rankless by CCL
2025